GlassScriptPhysician profile
Mikhail Galperin
NPI 1306136650
$3,801.91
in general payments reported to CMS, 2019-2025
9 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $68.71 · 2023: $340 · 2024: $2,069 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,102 · Food and Beverage: $1,474 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,101.98 |
| Food and Beverage | $1,474.27 |
| Education | $156.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,023.70 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Surgentec | $594.18 | 2025 | Tilink |
| Janssen Biotech, INC. | $454.00 | 2022-2025 | Stelara, Simponi Aria, Simponi |
| Globus Medical, INC. | $311.98 | 2025 | Senza, Vyrsa V1 |
| Takeda Pharmaceuticals U.S.A., INC. | $271.13 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Stryker Corporation | $68.40 | 2025 | Spinejack, Mild Device Kit, Optablate |
| Braintree Laboratories, INC. | $26.96 | 2023 | Sutab |
| Saluda Medical Americas, INC. | $26.96 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.60 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Galperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.